Position in NBIX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$212,312,700
+$48,582,279 QoQ
Shares Held
1,259,717
+1.4% QoQ
Ownership
1.24%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#15
of 768 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 96%
Shared 4%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $2,153,058,366 across 55 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (9.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
5,542,234 | $398,264,931 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
7,956,873 | $269,578,854 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
430,844 | $233,444,201 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
This page
|
1,259,717 | $212,312,700 | |
| 5 | VTRS |
Viatris Inc
|
10,038,691 | $159,414,410 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
4,256,056 | $104,741,534 | |
| 7 | ALKS |
Alkermes plc.
|
1,831,619 | $95,976,834 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
818,394 | $90,792,627 |
All Filings in NBIX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $212,312,700 | 1,259,717 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $163,730,421 | 1,242,830 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $173,200,524 | 1,221,184 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $129,951,726 | 925,714 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $116,773,296 | 929,058 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $105,875,165 | 957,280 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $134,034,671 | 981,939 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $88,906,516 | 771,624 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $111,598,054 | 810,620 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $98,622,177 | 715,068 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $106,367,343 | 807,281 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $94,876,087 | 843,343 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $79,986,390 | 848,212 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $88,629,242 | 875,610 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $102,902,574 | 861,542 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $91,144,640 | 858,155 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $84,838,986 | 870,322 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $82,789,779 | 883,091 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $74,473,583 | 874,411 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $87,642,460 | 913,799 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $87,184,995 | 895,859 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $93,457,539 | 961,003 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $60,759,504 | 633,902 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $61,747,699 | 642,135 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $82,802,254 | 678,707 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $51,634,775 | 596,589 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||